 CHATHAM, N.J., Oct. 07, 2021 GLOBE NEWSWIRE -- Tonix Pharmaceuticals Holding Corp. Nasdaq: TNXP Tonix or the Company, a clinical-stage biopharmaceutical company, announced that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, has been invited to participate in a panel discussion at the A.G.P. Fall Virtual Biotech Specialty Pharma Conference on October 13, 2021. 